Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.16 USD | +0.45% | -5.74% | -51.71% |
May. 08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
May. 08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EYEPOINT PHARMACEUTICALS, INC. | Other Pharmaceuticals | +0.45% | -5.74% | -51.71% | +88.20% | -31.95% | 581M |
Technical Rankings Surperformance
- Stock Market
- Equities
- EYPT Stock
- Charts EyePoint Pharmaceuticals, Inc.
- Comparison Chart